Correlations Between LP-PLA2 Gene Polymorphisms and Susceptibility and Severity of Acute Pancreatitis in a Chinese Population.

Genet Test Mol Biomarkers

2 Department of Gastrointestinal, Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, P.R. China .

Published: April 2017

Objective: This case-control study explored correlations between LP-PLA2 gene polymorphisms (A379V, V279F, and R92H) and susceptibility and severity of acute pancreatitis (AP) in a Chinese population.

Materials And Methods: From October 2013 to October 2015, 94 AP patients were chosen as the case group. According to the Acute Physiology and Chronic Health Evaluation (APACHE) II score standard, AP patients were divided into a mild AP (MAP) group (n = 46) and severe AP (SAP) group (n = 48). The 48 SAP patients were further divided into an SAP with multiple organ dysfunction syndrome (MODS) group (n = 42) and SAP without MODS group (n = 6). Meanwhile, 96 healthy subjects who received physical examinations at the study hospitals were selected as the control group. Serum lipoprotein-associated phospholipase A2 (LP-PLA2) levels were detected by an enzyme-linked immunosorbent assay (ELISA). The A379V (s1051931), V279F (rs16874954), and R92H (rs13989) polymorphisms of the LP-PLA2 gene were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

Results: There were significant differences in the frequencies of the LP-PLA2 gene polymorphisms between the AP group and the control group. The distribution of V279F-AA+AC genotype and R92H-AA+AG genotype in the AP group was higher than that in the control group, whereas the SAP group and SAP with MODS group distributions were higher than those in the MAP group and SAP without MODS group (both p < 0.05). G-C-A, G-A-G, and G-C-G haploids formed by A379V, V279F, and R92H may be associated with AP susceptibility. LP-PLA2 gene polymorphisms could affect serum LP-PLA2 level, whereas the V279F-A allele gene, the R92H-A allele gene, serum LP-PLA2 level, and serum amylase may be independent risk factors for AP (all p < 0.05).

Conclusion: These results demonstrated that the LP-PLA2 gene polymorphisms, V279F and R92H, may be associated with susceptibility to and severity of AP.

Download full-text PDF

Source
http://dx.doi.org/10.1089/gtmb.2016.0243DOI Listing

Publication Analysis

Top Keywords

lp-pla2 gene
16
mods group
16
group
14
gene polymorphisms
12
sap mods
12
control group
12
group sap
12
correlations lp-pla2
8
susceptibility severity
8
severity acute
8

Similar Publications

Purpose: This study aimed to investigate the distribution patterns of PLA2G7 gene variants in Han Chinese patients with coronary heart disease (CHD), and their relationships with serum lipoprotein-associated phospholipase A2 (Lp-PLA2) levels and lipid profiles.

Methods: A total of 93 han Chinese CHD patients were recruited. Serum Lp-PLA2 levels were determined using enzyme-linked immunosorbent assay (ELISA), while comprehensive analysis of PLA2G7 gene polymorphisms was conducted through whole-exome sequencing.

View Article and Find Full Text PDF

Background Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a key enzyme selectively expressed in unstable, rupture-prone atherosclerotic plaques. Previous research has established a strong link between the gene and the development of coronary artery disease (CAD). While traditional risk factors like cholesterol levels and blood pressure are valuable, there remains a need for more specific biomarkers to identify individuals at heightened risk of atherosclerosis before the onset of clinical symptoms.

View Article and Find Full Text PDF

Calcific aortic stenosis is the most prevalent valvular abnormality in the Western world. Factors commonly associated with calcific aortic stenosis include advanced age, male sex, hypertension, diabetes and impaired renal function. This review synthesises the existing literature on genetic associations with calcific aortic stenosis.

View Article and Find Full Text PDF
Article Synopsis
  • In mouse models, knocking out the PLA2G2A gene reduces atherosclerotic plaque volume, but clinical trials with the sPLA2 inhibitor Varespladib haven’t effectively lowered cardiovascular risk, highlighting the need for further research on PLA2G2A's mechanisms.
  • Using single-cell transcriptome data from carotid plaques with patient info, researchers found that PLA2G2A is mainly expressed in vascular fibroblasts and interacts significantly with macrophages, especially in early plaque stages related to inflammation.
  • The study concludes that PLA2G2A promotes early plaque progression by activating macrophage-related pathways and suggests its serum levels could be valuable for diagnosing mild carotid artery stenosis.
View Article and Find Full Text PDF
Article Synopsis
  • Lp-PLA2 plays a significant role in inflammatory responses during sepsis, as shown by its increased levels in septic mice and cell cultures.
  • Increased Lp-PLA2 levels were positively correlated with higher proinflammatory cytokine concentrations in sepsis patients, indicating its involvement in inflammation.
  • The study highlights a regulatory mechanism where Spi1 promotes Pla2g7 transcription, and manipulating these factors can reduce inflammatory responses and organ damage in septic conditions.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!